FDA Approves Wegovy to Treat Serious Liver Disease
Adults With Hearing Loss Using Hearing Aids Have Reduced Dementia Risk
Among those younger than 70 years at the time of HL diagnosis, risk for incident dementia was 61 percent lower for those with hearing aids
Risdiplam Beneficial for Infants With Genetically Diagnosed Spinal Muscular Atrophy
Improved functional, survival outcomes seen with risdiplam treatment before development of clinical signs or symptoms
Nasal Spray Flu Vaccine Now Available for At-Home Use
AAP Offers Guidance for Tapering of Opioids to Prevent Withdrawal in Children
Signs and symptoms linked with withdrawal are relatively consistent in pediatric population; can be seen after five or more days of opioids
Tdap, MenACWY Coverage Increased in Teens From 2023 to 2024
From 2023 to 2024, coverage with Tdap, MenACWY increased, while HPV vaccination coverage remained stable
High Response to PD-1 Therapy Seen in Unresectable Desmoplastic Melanoma
Complete response rate was 37 percent, and post-hoc end point of objective response rate was 89 percent
FDA Approves Ketamine Product, KETARx, for Surgical Pain Management
Drugmaker aims to pursue other applications in mental health, neurological, and pain disorders
Dalbavancin Noninferior to Standard Therapy for Complicated S. Aureus Bacteremia
Dalbavancin not superior to standard therapy, but met the noninferiority criterion
2009 to 2023 Saw Increase in Use of Technology, Glycemic Control in Type...
Prevalence of glycemic control and use of diabetes technology lowest in Hispanic, non-Hispanic Black, Medicaid-insured
